ASEAN-NDI and ASEAN DxD Hub
Call for Proposals: ASEAN DxD Initiative
The ASEAN Diagnostics Development (DxD) Initiative is pleased to accept R&D project proposals aligned with diagnostics for Dengue, Tuberculosis, Hepatitis B, and Malaria for CY 2019.
The ASEAN Diagnostics Development (DxD) Initiative is a joint program of Philippine’s ASEAN Network for Drugs, Diagnostics, Vaccines, and Traditional Medicines Innovation (ASEAN-NDI) and Singapore’s Diagnostics Development Hub (DxD Hub) which focus to co-develop diagnostic products among ASEAN Member States (AMS) that will address the unmet clinical needs in ASEAN. The initiative was approved by the ASEAN last May 2018 during its COST-74 meeting in Thailand.
The Initiative will give a priority to proposals that are strategically fit and beneficial to ASEAN. Likewise, medical value, workflow efficiency, competitive landscape, and commercial attractiveness in the development of product are important and necessary as the drugs/expected outcome should be market-ready.
- Completed project proposal template of ASEAN DxD Initiative
- Curriculum Vitae (CV) of team members
Chosen proposals will be co-funded by DxD Hub amounting to $50,000 USD. Visit aseandxd.com for the details of application such as proposal form and evaluation criteria.